VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations

NCT07629089 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Brain Cancer

Interventions

DRUG: Vorasidenib
DRUG: Lomustine

Sponsor

Megan Mantica

Collaborators

[object Object]